Adrenocortical Tumors: Prevalence of Impaired Glucose Tolerance and of "Paradoxical Rise" of Cortisol during an Oral Glucose Tolerance Test

Experimental and Clinical Endocrinology and Diabetes

Volumn 111, Issue 7, 2003, Pages 415-420

  Vierhapper, H ^a   Heinze, G ^a   Gessl, A ^a   Exner, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adrenal adenoma; Adrenal incidentaloma; Age; Body weight; Cortisol; Impaired glucose tolerance

Indexed keywords

DEXAMETHASONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; BODY MASS INDEX; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED;

EID: 0345714653     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44288     Document Type: Article

References (34)

1. Anderson WA, Kissane JM. Pathology. ed 7. St. Louis: Mosby 1977: 1671-1674
2. Andres R. Aging and diabetes. Med Clin North Amer 1991; 55: 835-846
3. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci 1999; 96: 513-523
4. Baumgartner-Parzer SM, Pauschenwein S, Waldhäusl W, Pölzler K, Nowotny P, Vierhapper H. Increased prevalence of heterozygous 21-OH germ line mutations in patients with adrenal incidentalomas. Clin Endocrinol 2002; 56: 811-816
5. Beuschlein F, Borgemeister M, Schirra J, Goke B, Fassnacht M, Arlt W, Allolio B, Reincke M. Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol 2000; 52: 617-623
6. Biermann EL, Bagdale JD, Porte D. Obesity and diabetes: the odd couple. Am J Clin Nutr 1968; 21: 1434-1437
7. Björntorp P. Visceral obesity: "a civilisation syndrome". Obes Res 1993; 1: 206-222
8. Dinnen S, Alzaid A, Miles J, Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest 1993; 92: 2283-2290
9. Everhart JE, Pettitt DJ, Bennett PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes 1992; 42: 235-240
10. Fernandez-Real JM, Engel WR, Simo R, Salinas I, Webb SM. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Clin Endocrinol 1998; 49: 53-61
11. Fruehwald-Schultes B, Kern W, Bong W, Wellhoener P, Kerner W, Born J, Fehm HL, Peters A. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab 1999; 84: 3041-3046
12. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 2001; 86: 5301-5306
13. Harris MI, Hadden WC, Knowler WC, Bennet PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes 1987; 36: 523-534
14. Hedeland H, Ostberg G, Hokfeld B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 1968; 184: 211-214
15. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989
16. Jarrett RJ, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84
17. Korbonits M, Trainer P, Nelson M, Howse I, Kopelman P, Besser G, Grossman A, Svec F. Differential stimulation of cortisol and dehydro-epiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin Endocrinol (Oxf) 1996; 45: 699-706
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
19. Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 1993; 76: 968-976
20. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol 2001; 54: 797-804
21. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's Syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992; 75: 826-832
22. Reincke M, Faßnacht M, Väth S, Mora P, Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 1996; 22: 757-761
23. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323: 1402-1405
24. Ross NS. Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab North Am 1994; 23: 539-546
25. Rossi R, Tauchmanova L, Luciano A, Dimartino M, Battista C, Delviscovo L, Nuzzo V, Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features. J Clin Endocrinol Metab 2000; 85: 1440-1448
26. Russi S, Blumenthal HT. Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 1945; 76: 284-291
27. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. New Engl J Med 1988; 319: 1500-1506
28. Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes 1976; 25: 241-244
29. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: A new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87: 998-1003
30. Vierhapper H. Adrenocortical tumors: clinical symptoms and biochemical diagnosis. Europ J Radiol 2002; 41: 88-94
31. Waldhäusl W, Herkner K, Nowotny P, Bratusch-Marrain P. Combined 17α- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism. J Clin Endocrinol Metab 1978; 46: 236-246
32. Waldhäusl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 1979; 28: 577-584
33. World Health Organization Study Group. Diabetes Mellitus. WHO Technical Report Series 727. Geneva, Switzerland: World Health Organization, 1985
34. Young WF. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocr Metab Clin North Am 2000; 29: 159-185